• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用多管齐下的方法来管理下游工艺中的β-葡聚糖污染物:通过电荷修饰的尼龙 6,6 膜过滤器控制原材料和过滤。

Multipronged approach to managing beta-glucan contaminants in the downstream process: control of raw materials and filtration with charge-modified nylon 6,6 membrane filters.

机构信息

Purification Process Development, Amgen Inc., Seattle, WA, USA.

出版信息

Biotechnol Prog. 2013 May-Jun;29(3):672-80. doi: 10.1002/btpr.1718. Epub 2013 Apr 18.

DOI:10.1002/btpr.1718
PMID:23596143
Abstract

(1→3)-β-D-Glucans (beta-glucans) have been found in raw materials used in the manufacture of recombinant therapeutics. Because of their biological activity, beta-glucans are considered process contaminants and consequently their level in the product needs to be controlled. Although beta-glucans introduced into the cell culture process can readily be removed by bind-and-elute chromatography process steps, beta-glucans can also be introduced into the purification process through raw materials containing beta-glucans as well as leachables from filters made from cellulose. This article reports a multipronged approach to managing the beta-glucan contamination in the downstream process. Raw material screening and selection can be used to effectively limit the level of beta-glucan introduced into the downstream process. Placement of a cellulosic filter upstream of the last bind-and-elute column step or effective preuse flushing can also limit the level of contaminant introduced. More importantly, this article reports the active removal of beta-glucan from the downstream process when necessary. It was discovered that the Posidyne(®) filter, a charge-modified nylon 6,6 membrane filter, was able to effectively remove beta-glucans from buffers at relatively low pH and salt concentrations. An approach of using low beta-glucan buffer components combined with filtration of the buffer with a Posidyne membrane has been successfully demonstrated at preparative scale. Additionally, the feasibility of active removal of beta-glucan from in-process product pools by Posidyne membrane filtration has also been demonstrated. Based on the data presented, a mechanism for binding is proposed, as well as a systematic approach for sizing of the Posidyne filter.

摘要

(1→3)-β-D-葡聚糖(β-葡聚糖)已在用于制造重组治疗药物的原材料中被发现。由于其生物活性,β-葡聚糖被视为过程污染物,因此需要控制其在产品中的水平。尽管在细胞培养过程中引入的β-葡聚糖可以通过结合-洗脱色谱过程步骤很容易地去除,但β-葡聚糖也可以通过含有β-葡聚糖的原材料以及由纤维素制成的过滤器的浸出物引入到纯化过程中。本文报告了一种多管齐下的方法来管理下游过程中的β-葡聚糖污染。原材料筛选和选择可有效限制引入下游过程的β-葡聚糖水平。在上游最后一个结合-洗脱柱步骤之前放置纤维素过滤器或有效的预冲洗也可以限制引入的污染物水平。更重要的是,本文报告了在必要时从下游过程中主动去除β-葡聚糖。发现 Posidyne(®)过滤器,一种带电荷修饰的尼龙 6,6 膜过滤器,能够在相对低的 pH 值和盐浓度下从缓冲液中有效去除β-葡聚糖。已经在中试规模成功证明了使用低β-葡聚糖缓冲成分结合 Posidyne 膜过滤缓冲液的方法。此外,还证明了通过 Posidyne 膜过滤从过程中产品池主动去除β-葡聚糖的可行性。基于呈现的数据,提出了一种结合机制,以及 Posidyne 过滤器的尺寸确定系统方法。

相似文献

1
Multipronged approach to managing beta-glucan contaminants in the downstream process: control of raw materials and filtration with charge-modified nylon 6,6 membrane filters.采用多管齐下的方法来管理下游工艺中的β-葡聚糖污染物:通过电荷修饰的尼龙 6,6 膜过滤器控制原材料和过滤。
Biotechnol Prog. 2013 May-Jun;29(3):672-80. doi: 10.1002/btpr.1718. Epub 2013 Apr 18.
2
Experimental proof of contamination of blood components by (1-->3)-beta-D-glucan caused by filtration with cellulose filters in the manufacturing process.在制造过程中,使用纤维素过滤器过滤导致血液成分被(1→3)-β-D-葡聚糖污染的实验证据。
J Artif Organs. 2003;6(1):49-54. doi: 10.1007/s100470300008.
3
Control of leached beta-glucan levels from depth filters by an improved depth filtration flush strategy.通过改进的深层过滤冲洗策略控制深层过滤器中浸出的β-葡聚糖水平。
Biotechnol Prog. 2021 Jan;37(1):e3086. doi: 10.1002/btpr.3086. Epub 2020 Oct 16.
4
Development of downstream processing to minimize beta-glucan impurities in GMP-manufactured therapeutic antibodies.开发下游加工工艺以尽量减少在符合药品生产质量管理规范(GMP)生产的治疗性抗体中的β-葡聚糖杂质。
Biotechnol Prog. 2016 Nov;32(6):1494-1502. doi: 10.1002/btpr.2359. Epub 2016 Oct 21.
5
Demonstrating β-glucan and yeast peptide clearance in biopharmaceutical downstream processes.展示生物制药下游工艺中β-葡聚糖和酵母肽的清除效果。
Biotechnol Prog. 2011 Mar-Apr;27(2):442-50. doi: 10.1002/btpr.568. Epub 2011 Mar 1.
6
Positive (1-->3)-beta-D-glucan in blood components and release of (1-->3)-beta-D-glucan from depth-type membrane filters for blood processing.血液成分中的阳性(1→3)-β-D-葡聚糖以及用于血液处理的深层膜过滤器中(1→3)-β-D-葡聚糖的释放。
Transfusion. 2002 Sep;42(9):1189-95. doi: 10.1046/j.1537-2995.2002.00162.x.
7
Pre-sampling contamination of filters used in measurements of airborne (1 → 3)-β-D-glucan based on glucan-specific Limulus amebocyte lysate assay.基于葡聚糖特异性鲎试剂法的空气中(1→3)-β-D-葡聚糖测量中使用的滤膜预采样污染
J Environ Monit. 2011 Apr;13(4):1082-7. doi: 10.1039/c0em00495b. Epub 2011 Feb 25.
8
Filtration membranes - Scavengers for leachables?过滤膜——浸出物的清除器?
Eur J Pharm Sci. 2018 Jul 30;120:191-198. doi: 10.1016/j.ejps.2018.04.044. Epub 2018 Apr 30.
9
Release of (1-->3)-beta-D-glucan from depth-type membrane filters and their in vitro effects on proinflammatory cytokine production.深度型膜过滤器中(1-->3)-β-D-葡聚糖的释放及其对促炎细胞因子产生的体外影响。
Artif Organs. 2003 Aug;27(8):728-35. doi: 10.1046/j.1525-1594.2003.07137.x.
10
Lipid content of microparticulate (1-->3)-beta-D-glucan isolated from Saccharomyces cerevisiae.从酿酒酵母中分离出的微粒状(1→3)-β-D-葡聚糖的脂质含量。
Microbios. 1994;79(321):253-61.

引用本文的文献

1
Utility and Pitfalls of β-D-Glucan for Diagnosis and Response Monitoring of Chronic Disseminated Candidiasis in Paediatric Cancer Patients.β-D-葡聚糖在儿科癌症患者慢性播散性念珠菌病诊断及反应监测中的应用与陷阱
Mycoses. 2025 Aug;68(8):e70102. doi: 10.1111/myc.70102.
2
Tuning hydrogen bonds and electrostatics with convection for purifying mRNA: A paradigm shift.通过对流调节氢键和静电作用以纯化mRNA:一种范式转变。
Sci Adv. 2025 Jun 20;11(25):eadv8656. doi: 10.1126/sciadv.adv8656. Epub 2025 Jun 18.
3
Influence of Nano-Particulate Impurities and β-glucans on the Stability of Protein-Based Formulations.
纳米颗粒杂质和β-葡聚糖对蛋白质制剂稳定性的影响。
Curr Drug Deliv. 2025;22(6):659-665. doi: 10.2174/0115672018290111240119115306.
4
Introduction and clearance of beta-glucan in the downstream processing of monoclonal antibodies.介绍和清除β-葡聚糖在单克隆抗体下游处理中的应用。
Biotechnol Prog. 2021 Jul;37(4):e3149. doi: 10.1002/btpr.3149. Epub 2021 Mar 31.
5
Specificity Influences in (1→3)-β-d-Glucan-Supported Diagnosis of Invasive Fungal Disease.特异性对(1→3)-β-D-葡聚糖在侵袭性真菌病诊断中的影响
J Fungi (Basel). 2020 Dec 29;7(1):14. doi: 10.3390/jof7010014.
6
Detection of Beta-Glucan Contamination in Nanotechnology-Based Formulations.检测纳米技术制剂中的β-葡聚糖污染。
Molecules. 2020 Jul 24;25(15):3367. doi: 10.3390/molecules25153367.